Diarrhea associated with lansoprazole

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3% of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.

Original languageEnglish
Pages (from-to)602-603
Number of pages2
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume18
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Lansoprazole
Diarrhea
Proton Pump Inhibitors
Microscopic Colitis
Product Labeling
Lakes
Gastroesophageal Reflux
Peptic Ulcer
Pharmaceutical Preparations
Abdominal Pain
Headache

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Hepatology

Cite this

Diarrhea associated with lansoprazole. / Mukherjee, Sandeep.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 18, No. 5, 01.05.2003, p. 602-603.

Research output: Contribution to journalArticle

@article{d9c8aaee7ba644cc866c11344f427d98,
title = "Diarrhea associated with lansoprazole",
abstract = "Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3{\%} of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.",
author = "Sandeep Mukherjee",
year = "2003",
month = "5",
day = "1",
doi = "10.1046/j.1440-1746.2003.02801.x",
language = "English",
volume = "18",
pages = "602--603",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Diarrhea associated with lansoprazole

AU - Mukherjee, Sandeep

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3% of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.

AB - Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3% of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0038392681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038392681&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1746.2003.02801.x

DO - 10.1046/j.1440-1746.2003.02801.x

M3 - Article

VL - 18

SP - 602

EP - 603

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 5

ER -